Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Liofilchem MIC Test Strip (MTS)-Vancomycin 0.016 -256 ug/mL

K-Number: K153687 · 2016-03-31

ApplicantLiofilchem s.r.l.
Decision Date2016-03-31
Product CodeJWY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Liofilchem MIC Test Strip (MTS)-Vancomycin 0.016 -256 ug/mL is the device name listed in this FDA 510(k) record. The listed applicant is Liofilchem s.r.l.. It received FDA 510(k) clearance on 2016-03-31 under 510(k) number K153687. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Liofilchem MIC Test Strip (MTS)-Vancomycin 0.016 -256 ug/mL?

Liofilchem MIC Test Strip (MTS)-Vancomycin 0.016 -256 ug/mL is a medical device that received FDA 510(k) clearance on 2016-03-31. The listed applicant is Liofilchem s.r.l.. The 510(k) number is K153687.

When did Liofilchem MIC Test Strip (MTS)-Vancomycin 0.016 -256 ug/mL receive FDA 510(k) clearance?

Liofilchem MIC Test Strip (MTS)-Vancomycin 0.016 -256 ug/mL received FDA 510(k) clearance on 2016-03-31, under 510(k) number K153687.

Who is the listed applicant for Liofilchem MIC Test Strip (MTS)-Vancomycin 0.016 -256 ug/mL?

The FDA 510(k) record lists Liofilchem s.r.l. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Liofilchem MIC Test Strip (MTS)-Vancomycin 0.016 -256 ug/mL?

The FDA product code for Liofilchem MIC Test Strip (MTS)-Vancomycin 0.016 -256 ug/mL is JWY.

Other records listing Liofilchem s.r.l. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260696MTS Gepotidacin 0.016-256 µg/mLK252114MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mLK251580MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD)K243202MTS Ceftobiprole 0.002-32 µg/mLK230479ComASP Cefiderocol 0.008-128K211672MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL

View all 35 devices →

Related Devices (Code: JWY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260447ETEST Gepotidacin (GEP) (0.016-256 µg/mL)bioMérieux SAK260696MTS Gepotidacin 0.016-256 µg/mLLiofilchem s.r.l.K252114MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mLLiofilchem s.r.l.K252062The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mLThermo Fisher ScientificK250575The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mLThermo Fisher ScientificK252014The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mLThermo Fisher Scientific

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑